2001
DOI: 10.1016/s0264-410x(01)00190-6
|View full text |Cite
|
Sign up to set email alerts
|

Antigenic and molecular heterogeneity in recent swine influenza A(H1N1) virus isolates with possible implications for vaccination policy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
23
0
1

Year Published

2006
2006
2019
2019

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 35 publications
(24 citation statements)
references
References 19 publications
0
23
0
1
Order By: Relevance
“…It is commonly thought that SwIV undergoes less antigenic rstb.royalsocietypublishing.org Phil Trans R Soc B 368: 20120382 change than human influenza viruses [33,34], possibly because the short lifespan of farmed swine (approx. 150 days) lowers the chance of re-infection.…”
Section: Discussionmentioning
confidence: 99%
“…It is commonly thought that SwIV undergoes less antigenic rstb.royalsocietypublishing.org Phil Trans R Soc B 368: 20120382 change than human influenza viruses [33,34], possibly because the short lifespan of farmed swine (approx. 150 days) lowers the chance of re-infection.…”
Section: Discussionmentioning
confidence: 99%
“…Similarly, there were only low to moderate degrees of cross-reactivity among recent H1N1 and H1N2 SIV isolates from the United States (53). These studies indicate that genetic and antigenic heterogeneities that might reduce vaccine effectiveness occur within each subtype of SIV (5,42). In addition, killed-virus vaccine formulations induce mainly humoral immune responses while complete protection from SIV infections might require both humoral and cell-mediated immunity (16).…”
mentioning
confidence: 83%
“…For this, five reference antigens of influenza were used: A/swine/Netherlands/Best/96 (European swine H1N1) (de Jong et al, 2001), A/swine/Gent/7625/99 (European swine H1N2) (Marozin et al, 2002), A/swine/Netherlands/St Oedenrode/96 (European swine H3N2) (de Jong et al, 1999), A/Port Chalmers/1/73 (H3N2 of human origin) (Schild et al, 1974) and A/Netherlands/602/2009 (pandemic H1N1) (Munster et al, 2009). …”
Section: Antibodies Against Swine Influenza Virus (Siv)mentioning
confidence: 99%